BMY FY 2010 Earnings — Bristol-Myers Squibb Company Revenue & Financial Results | Market Cap Arena

BMYBristol-Myers Squibb Company

$120B

FY 2010 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$19.5B+3.6% YoY

Gross Profit

$14.3B73.5% margin

Operating Income

$6.1B31.5% margin

Net Income

$3.1B15.9% margin

EPS (Diluted)

$1.80

Cash Flow

Operating Cash Flow

$4.5B

Free Cash Flow

$4.1B

Stock-Based Comp.

$193M

Balance Sheet

Total Assets

$31.1B

Total Liabilities

$15.4B

Stockholders' Equity

$15.7B

Cash & Equivalents

$5.0B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$19.5B	$18.8B	+3.6%
Gross Profit	$14.3B	$13.8B	+4.0%
Operating Income	$6.1B	$5.0B	+21.6%
Net Income	$3.1B	$10.6B	-70.8%